|
1 Company |
|
0 Products |
|
0 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
7 News |
|
- |||| Trial completion: Apatone-B: Double-Blinded Clinical Trial Using Apatone (clinicaltrials.gov) - Jan 31, 2018
P2, N=57, Completed, Sponsor: IC-MedTech Corporation
Active, not recruiting --> Completed
- Trial primary completion date: Apatone-B: Double-Blinded Clinical Trial Using Apatone (clinicaltrials.gov) - Apr 19, 2015
P2, N=60, Active, not recruiting, Sponsor: IC-MedTech Corporation
Active, not recruiting --> Completed Trial primary completion date: Dec 2013 --> Dec 2014
- mesna / Generic mfg.
Trial termination: Chemically Assisted Capsulectomy-A New Clinical Approach (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=20, Terminated, Sponsor: Vanderbilt University
Trial primary completion date: Dec 2013 --> Dec 2014 Withdrawn --> Terminated; preliminary analysis showed no difference
- Enrollment closed: IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee. (clinicaltrials.gov) - Jul 18, 2014
P1/2, N=35, Active, not recruiting, Sponsor: UMC Utrecht
Withdrawn --> Terminated; preliminary analysis showed no difference Recruiting --> Active, not recruiting
- New P1/2 trial: IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee. (clinicaltrials.gov) - Jan 12, 2014
P1/2, N=35, Recruiting, Sponsor: UMC Utrecht
- Enrollment open: IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee. (clinicaltrials.gov) - Jan 12, 2014
P1/2, N=35, Recruiting, Sponsor: UMC Utrecht
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Enrollment closed: Apatone-B: Double-Blinded Clinical Trial Using Apatone (clinicaltrials.gov) - Nov 19, 2013
P2, N=60, Active, not recruiting, Sponsor: Summa Health System
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting